Calcium supplied in the mineral form found in bone, manufactured from bovine bone and containing phosphorus, collagen fragments and trace minerals alongside the calcium. Sold on the premise that a bone-like matrix is better used by bone.
The argument for hydroxyapatite is intuitive and weakly evidenced. A small number of older European studies, mostly of ossein-hydroxyapatite complex, reported bone density effects, but the trials are dated, small and not readily compared with modern calcium research. Absorption studies have found hydroxyapatite absorbed comparably to or slightly less well than other calcium salts. The consideration that distinguishes it is sourcing: it is an animal bone product, and bone concentrates lead, which has led to repeated recommendations to check heavy-metal testing on this specific category.
Sold as
Tablet, Capsule, Ossein-hydroxyapatite complex, Combination with vitamin D and K
Regulation: Subject to the same calcium RDA and upper limit as any calcium source. Bone-derived supplements have historically attracted regulatory attention over lead content, and in some jurisdictions over bovine spongiform encephalopathy sourcing controls.
What the research used
The amounts, forms and durations published trials of Calcium hydroxyapatite (MCHC) actually administered.
These are the amounts published trials administered — not a recommendation, and not a dose to copy. Trial participants were screened, supervised and given a characterised preparation. What is in a retail bottle is frequently not what was studied, and the amount that suits one person is not general advice.
Studied for Typical retail supplement
500–1000 mg
Not enough
Elemental calcium from MCHC, daily
Labels frequently state the total MCHC weight rather than elemental calcium, which overstates the calcium dose considerably. The phosphorus supplied alongside also counts toward phosphorus intake.
Studied for Older bone density studies
700–1200 mg
Limited
Ossein-hydroxyapatite complex, daily · 1–2 years
Small European trials from the 1980s and 1990s, with methods reported in limited detail and little modern replication.
This is general information about food, not medical advice. It cannot diagnose, treat or replace guidance from a clinician who knows your history.
When it was taken
Each window says whether a trial compared it against an alternative, or whether it is convention and pharmacology. Most timing advice is the second kind.
None of the timings below were directly compared in a trial. They reflect how the research happened to dose, or what the pharmacology implies — which is not the same as a timing being better.
🍽️With food
Not enough
Taken with meals by convention and for tolerability. No comparative timing study exists for this form.
Timing was not directly compared. This reflects convention or how the compound behaves in the body, not a trial showing this window works better.
The evidence in depth
Best supported: Limited
What each association actually rests on, and the papers behind it. A rating describes the state of the research, not how promising the supplement sounds. How we rate evidence.
Small older trials of ossein-hydroxyapatite reported effects on bone density, and some comparisons suggested an advantage over carbonate. The studies are dated and small, absorption studies do not show superiority, and no modern fracture trial has used this form.
Limited evidence. Early human work, or mostly lab and animal research.
Meta-analysis · Menopause (New York, N.Y.) · 2009 · PMID 19407667
Deep research mode adds each paper’s own conclusion and stated limitations.
Things to know
Interactions, contraindications and dose limits, most serious first. Concentrated extracts interact with medication in ways the whole plant does not, so this section carries more weight here than it does on a food page.
Worth knowing
Lead content in bone-derived products
Bone accumulates lead over an animal's lifetime, and analyses of bone meal and bone-derived calcium supplements have repeatedly found measurably higher lead than other calcium salts. Third-party heavy-metal testing is worth insisting on, and these products are a poor choice in pregnancy and for children.
Interaction
Same medicine interactions as other calcium salts
Interacts withLevothyroxine, tetracyclines, fluoroquinolones, bisphosphonates, iron supplements
Reduces absorption of levothyroxine, tetracyclines, fluoroquinolones, bisphosphonates and iron; separation by several hours is standard.
Too much
Phosphorus load
Hydroxyapatite supplies phosphorus alongside calcium. That is irrelevant for most people but matters in chronic kidney disease, where phosphate restriction is often part of management.
Worth knowing
Animal sourcing
This is a bovine bone product, unsuitable for vegetarians and vegans, and sourcing controls vary between manufacturers and countries.